SEMIZLIK FONIDA YURAK ISHEMIK KASALLIGINING KLINIK-FUNKSIONAL VA GENETIK PREDIKTORLARI
Article Sidebar
Main Article Content
Аннотация:
Semizlik va yurak ishemik kasalligi (YIK) inson salomatligi uchun jiddiy xavf omillari sifatida global tibbiyotda katta e’tibor qaratilmoqda. Ushbu tezis semizlik fonida YIK rivojlanishining klinik-funksional va genetik prediktorlarini o‘rganishga bag‘ishlangan. Tadqiqot maqsadi semizlikning YIKga ta’sirini aniqlash, asosiy klinik va funksional belgilarga e’tibor qaratish, shuningdek genetik markerlar yordamida predispozitsiyani baholashdir. Olingan natijalar semizlik va yurak kasalliklari o‘rtasidagi murakkab o‘zaro bog‘liqlikni ochib beradi va individual riskni aniqlashga yordam beradi.
Article Details
Как цитировать:
Библиографические ссылки:
World Health Organization. Obesity and overweight. WHO, 2021, p. 12-15.
Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation, 2019, p. e56–e528.
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2017: a systematic analysis. The Lancet, 2018, p. 1659–1724.
Lavie CJ, De Schutter A, Milani RV. Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol, 2015, p. 55–62.
Khera AV, Emdin CA, Drake I, et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med, 2016, p. 160–169.
Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med, 2016, p. 364–373.
Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens, 2000, p. 655–673.
Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet, 2008, p. 56–63.
Chien KL, Su TC, Hsu HC, et al. Obesity and risk of ischemic stroke: the role of the metabolic syndrome. Stroke, 2008, p. 111–117.
Kannel WB, Wilson PW. Risk factors that attenuate the female coronary advantage. Arch Intern Med, 1995, p. 175–181.
Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity on the cardiovascular system. J Am Coll Cardiol, 2018, p. 1443–1458.
Ridker PM, MacFadyen JG, Thuren T, et al. Interleukin-6 inhibition and cardiovascular risk in patients with chronic inflammation: analysis of genetic markers. Circulation, 2020, p. 1300–1311